Trial intelligence / Profile preview

Trimipramine vs placebo for relapse temptation in methamphetamine dependency

IRCT20150822023705N12Phase 2Completed

Sponsor
Kermanshah University of Medical Sciences
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial in methamphetamine use disorder (MUD) comparing Trimipramine with Placebo (2 arms). Primary endpoints: Temptation to use methamphetamine and Rate of relapse to methamphetamine use. Started Jul 2019; status: completed.

02

Drugs

trimipramine
03

Conditions

methamphetamine use disorder (MUD)

Beyond the preview

Go deeper on IRCT20150822023705N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20150822023705N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call